Evidence map›Paper›PMID 25093975›Full record

ArticleThe Pediatric infectious disease journal2014

Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Andrew F Auld, Moise Z Tuho, Kunomboa A Ekra, Ray W Shiraishi, Fayama Mohamed, Joseph S Kouakou, Virginie Ettiègne-Traoré, Jennifer Sabatier, Joseph Essombo, Emilia D Rivadeneira and 3 more

Abstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Survival of HIV-1 vertically infected children.Current opinion in HIV and AIDS · 2016
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrew F AuldFrom the *Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, GA; †Ministry of Health, National Program for Medical Care of Persons Living with HIV/AIDS; ‡Division of Global HIV/AIDS, Centers for Disease Control and Prevention; §Elizabeth Glazer Pediatric AIDS Foundation; ¶Directorate General of Budget and Finance, Department of Economy and Finance, Abidjan, Côte d'Ivoire; and ‖Elizabeth Glazer Pediatric AIDS Foundation, Los Angeles, CA.
Moise Z Tuho
Kunomboa A Ekra
Ray W Shiraishi
Fayama Mohamed
Joseph S Kouakou
Virginie Ettiègne-Traoré
Jennifer Sabatier
Joseph Essombo
Emilia D Rivadeneira
Georgette Adjorlolo-Johnson
Richard Marlink
Tedd V Ellerbrock

Funding

Intramural CDC HHS CC999999PEPFAR
6 · The paper itself

Abstract

backgroundDuring 2004-2008, >2000 children (<15 years old) initiated antiretroviral therapy (ART) in Côte d'Ivoire. Nationally representative outcomes, temporal trends in outcomes during 2004-2008 and site-level outcome determinants have not been investigated.

methodsIncidence rates of death, loss to follow-up (LTFU) and attrition (death or LTFU) were evaluated in a nationally representative, retrospective cohort study among 2,110 children, who initiated ART at 29 facilities in Côte d'Ivoire during 2004-2008.

resultsAt ART initiation, 54% were male, 1% was HIV-2-infected and median age was 5.1 years. Median CD4% was 11%, and 61% had weight-for-age Z-score (WAZ) ≤-2. Vaccination completion was documented for 9% of children. Eleven of 29 facilities had an integrated nutrition program. Over 4585 person-years of ART, 237 children died and 427 became LTFU. Twelve-month attrition was 22% overall, but increased from 4% to 34% during 2004-2008, due to increases in 12-month mortality (from 3-11%) and 12-month LTFU (from 2% to 23%). In adjusted analysis, compared with enrollees in 2004, enrollees in 2008 had nearly 4-fold higher mortality and 8-fold higher LTFU. World Health Organization stage III/IV, CD4% <10%, WAZ ≤ 2 and hemoglobin <8 g/dL, were predictive of mortality. Incomplete vaccination was predictive of mortality and LTFU. Facilities with nutrition programs had lower LTFU and mortality rates. Clinics reporting nurse dissatisfaction with working conditions had higher LTFU rates.

conclusionInvestigation of causes of increasing mortality and LTFU is needed. Ensuring earlier ART initiation, vaccination completion, scale-up of site-level nutrition programs and nurse work-environment satisfaction, could improve pediatric ART program outcomes.

Indexed as

HIV-1HIV-2Lost to Follow-UpAdolescentAmbulatory Care FacilitiesAnti-HIV AgentsCD4 Lymphocyte CountChildChild, PreschoolCote d'IvoireFemaleHemoglobinsHIV InfectionsHumansInfantJob SatisfactionAnti-HIV AgentsHemoglobins

Identifiers

PMID25093975
PMCPMC11440633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.